Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer. (2023)

First Author: Wills C
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/gcc.23133

PubMed Identifier: 36790221

Publication URI: http://europepmc.org/abstract/MED/36790221

Type: Journal Article/Review

Volume: 62

Parent Publication: Genes, chromosomes & cancer

Issue: 6

ISSN: 1045-2257